Testing effectiveness (Phase 2)WithdrawnNCT03982537What this trial is testingEffect of N-Acetyl Cysteine (NAC) on the Oral MicrobiomeWho this might be right forHead and Neck Cancer Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT06281886What this trial is testingInduction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell CarcinomaEfficacyToxicity Sun Yat-sen University 170
Not applicableStudy completedNCT03381651What this trial is testingDifferent Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous CarcinomaWho this might be right forEsophageal CarcinomaNeoadjuvant ChemoradiotherapySurgery Zhejiang Cancer Hospital 147
Testing effectiveness (Phase 2)Study completedNCT02048020What this trial is testingPaclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerWho this might be right forHuman Papilloma Virus InfectionStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the Larynx+13 more Jonsson Comprehensive Cancer Center 26
Large-scale testing (Phase 3)Looking for participantsNCT07554456What this trial is testingBL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02)Who this might be right forEsophageal Squamous Cell Carcinoma Sichuan Baili Pharmaceutical Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT01412229What this trial is testingInduction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck Cancer UNC Lineberger Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT03624231What this trial is testingFeasibility & Efficacy of Durvalumab+Tremelimumab+RT and Durvalumab+RT in Non-resect. Locally Advanced HPVnegativ HNSCCWho this might be right forSquamous Cell Carcinoma of the Head and Neck Ulrich Keilholz 18
Large-scale testing (Phase 3)UnknownNCT03815903What this trial is testingInduction Chemotherapy for Locally Advanced Head and Neck Squamous Cell CarcinomaWho this might be right forLocally Advanced Malignant Neoplasm Barretos Cancer Hospital 434
Testing effectiveness (Phase 2)Looking for participantsNCT07086469What this trial is testingSurufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell CarcinomaWho this might be right forToripalimabSurufatinibNeoadjuvant Immunochemotherapy+2 more Sun Yat-sen University 69
Testing effectiveness (Phase 2)Study completedNCT03356223What this trial is testingEvaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6Who this might be right forHead and Neck CancerAdvanced CancerMetastatic Cancer Centre Leon Berard 25
Testing effectiveness (Phase 2)Looking for participantsNCT06272214What this trial is testingAdjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of ImmunotherapyWho this might be right forAdjuvant Radiotherapy Zhejiang Cancer Hospital 146
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06703047What this trial is testingTislelizumab Combined with Chemotherapy and All Trans Retinoic Acid for Locally Advanced or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Fudan University 180
Not applicableStudy completedNCT00502463What this trial is testingInduction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical TrialWho this might be right forHead and Neck Cancer Austrian South Oncology Group 51
Large-scale testing (Phase 3)UnknownNCT00336947What this trial is testingS-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck CancerWho this might be right forHead and Neck Cancer Yokohama City University 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07836049What this trial is testingPhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Vanderbilt-Ingram Cancer Center 20
Testing effectiveness (Phase 2)UnknownNCT01301248What this trial is testingCisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and NeckWho this might be right forHead and Neck NeoplasmsAJCC Stage III/IV Theagenio Cancer Hospital 80
Large-scale testing (Phase 3)Looking for participantsNCT04973306What this trial is testingNeoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Stage IIEsophageal Squamous Cell Carcinoma Stage III Shanghai Zhongshan Hospital 176
Not applicableStudy completedNCT03821064What this trial is testingSingle-arm Phase II Study of NDURE for Patients With HNCWho this might be right forCancer of Head and Neck Medical University of South Carolina 11
Testing effectiveness (Phase 2)Study completedNCT04552769What this trial is testingAbemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid CancerWho this might be right forThyroid CancerAnaplastic Thyroid CancerUndifferentiated Thyroid Cancer Stanford University 9
Large-scale testing (Phase 3)Study completedNCT01542931What this trial is testingTPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell CarcinomaWho this might be right forStage III Oral Cavity Squamous Cell CarcinomaStage IVA Oral Cavity Squamous Cell Carcinoma Shanghai Jiao Tong University School of Medicine 256